-
EXCLUSIVE: First Wave BioPharma CEO Talks COVID-19 Trial, Says 'If The Data Is Positive, I Think The Sky Is The Limit For Our Stock'
Thursday, January 6, 2022 - 6:21pm | 434Read More...First Wave BioPharma Inc (NASDAQ: FWBI) announced Thursday it completed enrollment for Part 2 of the RESERVOIR Phase 2 trial evaluating FW-COV, the company's oral tablet being developed to treat SARS-CoV-2, as an outpatient treatment for COVID-19-related...
